Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: TS-1 and Eloxatin
Sponsor: Seoul National University Hospital
Collaborators: Korean Cancer Study Group|National Cancer Center, Korea|Seoul National University Bundang Hospital|Samsung Medical Center|Asan Medical Center|Severance Hospital